BUSINESS● LOW3h ago · Oct 30, 2026, 12:40 AM
BridgeBio signals 3 launches in next 7 months with BBP-418 November 27 PDUFA and infigratinib February 4, 2027 PDUFA
Seeking Alpha Tech · global
BridgeBio is planning three product launches within the next seven months, with specific PDUFA dates for BBP-418 on November 27 and infigratinib on February 4, 2027. This indicates upcoming pharmaceutical product developments for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS10m agoFriday’s Economic CalendarSeeking Alpha TechBUSINESS10m ago5 things Westminster doesn’t really know about the UK economy (but probably should)Politico Europe